As of December 2024, AIM Vaccine has a market cap of $403.82M. This makes AIM Vaccine the world's 12903th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $404.45M | -18.60% |
2023 | $496.86M | 12165.62% |
2022 | $4.05M | - |